Morning Overview on MSN
First human trial tests gene therapy aimed at reversing cellular aging
For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...
The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka ...
The company described the round as fully subscribed and said the cash should keep operations running into the second half of ...
Zhou’s study, "TBX20 improves contractility and mitochondrial function during direct human cardiac reprogramming," was recently published in Circulation. The most common cause of death worldwide is ...
Peer-reviewed discovery platform and data in PNAS show that single transcription factor modulation reverses aging-associated gene expression and restores healthy cellular and tissue function in models ...
Ageing reversal may be closer than we think – scientists have begun human trials to test anti-ageing methods.
Unlike transient innate immune activation, trained immunity is characterized by long-lasting but reversible functional reprogramming of monocytes, macrophages, natural killer (NK) cells, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results